International Flavors (IFF) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

For the quarter ended September 2024, International Flavors (IFF) reported revenue of $2.93 billion, up 3.7% over the same period last year. EPS came in at $1.04, compared to $0.89 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $2.83 billion, representing a surprise of +3.25%. The company delivered an EPS surprise of -1.89%, with the consensus EPS estimate being $1.06.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how International Flavors performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Net Sales- Nourish: $1.49 billion versus $1.44 billion estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +2.6% change. Net sales- Scent: $613 million versus $629.75 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a -0.3% change. Net Sales- Pharma Solutions: $256 million versus the five-analyst average estimate of $240.35 million. The reported number represents a year-over-year change of +7.6%. Net Sales- Health & Biosciences: $570 million versus $531.83 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +10% change. Adjusted Operating EBITDA- Nourish: $206 million versus $207.69 million estimated by five analysts on average. Adjusted Operating EBITDA- Pharma Solutions: $62 million compared to the $47.74 million average estimate based on five analysts. Adjusted Operating EBITDA- Scent: $127 million versus the five-analyst average estimate of $137.51 million. Adjusted Operating EBITDA- Health & Biosciences: $173 million compared to the $155.24 million average estimate based on five analysts. View all Key Company Metrics for International Flavors here>>>Shares of International Flavors have returned -1.8% over the past month versus the Zacks S&P 500 composite's -0.5% change. The stock currently has a Zacks Rank #1 (Strong Buy), indicating that it could outperform the broader market in the near term.Research Chief Names "Single Best Pick to Double"From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report International Flavors & Fragrances Inc. (IFF): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks